Foresight Diagnostics, a pioneering precision medicine company, has successfully raised $33 million in funding to further advance its innovative liquid biopsy test aimed at detecting minimal residual disease (MRD). Based in Aurora, Colorado, Foresight’s cutting-edge cell-free DNA testing platform was meticulously developed in the prestigious labs of renowned Stanford University professors, giving the company a robust scientific foundation supported by numerous major peer-reviewed publications. This latest funding round, led by top-tier diagnostics venture capital firms in Silicon Valley, underscores the growing confidence in Foresight’s technology and its potential to revolutionize patient management in oncology. With significant interest from various pharmaceutical companies targeting cancer therapies, Foresight is strategically positioned for rapid growth, aiming to integrate its MRD measurement capabilities into clinical practice. The funding will be instrumental in scaling operations, enhancing research and development efforts, and expanding partnerships to bring this game-changing liquid biopsy test to market. As the healthcare landscape continues to evolve, Foresight Diagnostics stands at the forefront of precision medicine, dedicated to improving patient outcomes through innovative diagnostic solutions. The future looks bright for this dynamic company as it embarks on this exciting journey towards transforming the way we approach cancer treatment and patient management.

Precision Medicine Breakthrough: Foresight Diagnostics Secures $33M in Series B Funding Round
Get the full Foresight Diagnostics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Chatsee
Share anonymously with strangers & make new friends with Chatsee for iOS https://chats.ee/download/
$6.5M Seed
today

Sybilla Technologies
Sybilla Technologies designs, builds, and operates robotic optical observatories for monitoring objects in space. Company specializes in the software for automated data acquisition, analysis and scheduling of networks of sensors, as well as designing and building turnkey observatories. We work in the domains of Space Situational Awareness, Space Surveillance and Tracking, Space Traffic Management, Near Earth Objects, stellar and planetary research, education, and commercial on-demand observations.
$9.3M Seed
today

esVolta, LP
Focused on sustainability and innovation, esVolta develops, owns, and operates reliable utility-scale energy storage assets across the entire lifecycle - delivering value for utilities, energy users, and investors.
$450.0M Unknown
today

Sleek
✅ Built by entrepreneurs, for entrepreneurs, Sleek’s mission is to make the lives of our fellow entrepreneurs easier. ? It is the easiest way to get started and manage a business day to day. Just one platform to digitally manage company incorporation, compliance, bookkeeping & accounting, payroll, reporting, taxes and SO much more. Sleek's human-first, tech-enabled approach helps entrepreneurs automate repetitive tasks, while our supportive experts offer the best, personalised advice to our customers. ? Present across Singapore, UK, Australia and Hong Kong, Sleek has served over 450,000 clients across 110 countries, and processed millions of bookkeeping transactions digitally. ? Sleek is registered with the company registry and tax authorities of Singapore, Hong Kong, Australia and the UK. We are also regulated by the Monetary Authority of Singapore under the Payment Services Act, and issued a Major Payment Institution (MPI) licence No. PS20200521.
$9.0M Series a
today

ARYA
GPSR ARYA Private Limited, a subsidiary of GPS Renewables Private Limited; is a high quality climate infrastructure platform with a prime focus on driving biofuels and industrial decarbonization projects, end-to-end. Inspired from the name of Aryabhatta, the renowned Indian Mathematician and Astronomer, known for his invention of ‘Zero’ and also of India’s first satellite; ARYA has been established with the one-pointed objective of responding to Climate Change by solving for Net Zero. The projects incubated, executed and commissioned under ARYA would encompass the entire array of bioenergy solutions ranging from Bio-CNG to 1G and 2G Ethanol.
$76.8M Series c
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() ChAbS (Chinese Antibody Society) United States | Series b | $101.0M | today |
| 2 | ![]() EqualAI United States | Series b | $30.0M | today |
| 3 | ![]() PhoenixAI United States | Series b | $80.0M | 1d ago |
| 4 | ![]() Coram AI United States | Series b | $35.0M | 1d ago |
| 5 | ![]() City Therapeutics | Series b | $99.5M | 2d ago |
.png&w=3840&q=75)



